WHO suspends hydroxychloroquine testing over safety concerns

Your browser doesn’t support HTML5

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns as it urges countries to put in place comprehensive strategies to ensure a downward trajectory of cases of COVID-19. Plus, Hong Kong’s Chief Executive tries to quell concerns over Beijing's new national security law proposal and a pair of NASA astronauts prepare to blast off.